financetom
Business
financetom
/
Business
/
Novonix Obtains Japanese Patent for Battery Technology
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novonix Obtains Japanese Patent for Battery Technology
Jun 27, 2024 12:55 AM

03:43 AM EDT, 06/27/2024 (MT Newswires) -- Novonix ( NVX ) said late Wednesday it has been granted a Japanese patent for its cathode synthesis technology.

The battery materials company said the technology produces no waste.

The company has 10 categories of patent applications under examination in different jurisdictions, it said.

Price: 2.1100, Change: +0.05, Percent Change: +2.43

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Madison Square Garden Q4: Topline Growth, Events And Merchandise Lead Charge
Madison Square Garden Q4: Topline Growth, Events And Merchandise Lead Charge
Aug 16, 2024
Madison Square Garden Entertainment Corp ( MSGE ) stock gained after it reported its fiscal fourth-quarter results. Revenue rose 26% year-on-year to $186.1 million, beating the analyst consensus estimate of $169.6 million.  Adjusted EPS loss of $(0.53) missed the analyst consensus loss estimate of $(0.52). Also Read: Madison Square Garden Has Room For ‘Robust Growth’ Thanks To Concert Lineup, Christmas Spectacular: Analyst Revenues from...
AN2 Therapeutics Adopts Rights Plan After BML Investment Partners Nears 20% Stake
AN2 Therapeutics Adopts Rights Plan After BML Investment Partners Nears 20% Stake
Aug 16, 2024
08:35 AM EDT, 08/16/2024 (MT Newswires) -- AN2 Therapeutics ( ANTX ) said Friday it adopted a shareholder rights plan after investor BML Investment Partners acquired additional shares to increase its stake in the pharmaceutical firm to nearly 20% within a week. BML has acquired a total of 19.3% of AN2's stock as of Wednesday, a jump from a 14.2%...
Canopy Growth Down Slightly In US Premarket As Reveals CEO Succession Plan; David Klein to Retire at End of Fiscal Year
Canopy Growth Down Slightly In US Premarket As Reveals CEO Succession Plan; David Klein to Retire at End of Fiscal Year
Aug 16, 2024
08:40 AM EDT, 08/16/2024 (MT Newswires) -- Canopy Growth Corporation ( CGC ) , a global cannabis company, was at last look down 0.1% in US premarket on Friday as ait announced that CEO David Klein will be retiring at the conclusion of the company's current fiscal year ending March 31, 2025. Until this date or such time that a...
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
Aug 16, 2024
08:39 AM EDT, 08/16/2024 (MT Newswires) -- (Updates with missed target, stock movement in headline and lead paragraph, and additional details.) Shares of BioNTech (BNTX) were down 4% in Friday's premarket session after the biotech firm and Pfizer ( PFE ) reported that their phase 3 study assessing a combined mRNA vaccine candidate targeting influenza and COVID-19 missed one of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved